Sukcesywne dostawy produktów farmaceutycznych dla Szpitali Pomorskich Sp. z o.o. - produkty farmaceutyczne – programy lekowe 2026v62
10 fournisseurs attributaires•16 lots attribués•2,33 M € attribués
Acheteur: Szpitale Pomorskie Sp. z o.o. / Gdynia, Poland
Valeur attribuée
2,33 M €
Valeur estimée
2,33 M €
Attribué à 100% de la valeur estimée
Date d'attribution
31 mai 2026
Lauréats
10
Lots attribués
16
Valeurs d'attribution
Total de l'avis
2,33 M €
Somme des lots
2,31 M €
Le total de l'avis TED et les valeurs par lot ne correspondent pas exactement.
Lauréats
Warszawa, POL
836 065 € Ce contrat
21 avis d’attribution•37 lots attribués•27,45 M € au total
Warszawa, POL
657 634 € Ce contrat
37 avis d’attribution•69 lots attribués•65,25 M € au total
Warszawa, POL
657 634 € Ce contrat
10 avis d’attribution•10 lots attribués•526 882 € au total
Warszawa, POL
268 922 € Ce contrat
14 avis d’attribution•21 lots attribués•14,76 M € au total
Warszawa, POL
148 595 € Ce contrat
138 avis d’attribution•198 lots attribués•48,25 M € au total
Toruń, POL
104 229 € Ce contrat
2 avis d’attribution•2 lots attribués•873 788 € au total
Poznań, POL
82 243 € Ce contrat
54 avis d’attribution•151 lots attribués•13,81 M € au total
Budapest, HUN
41 931 € Ce contrat
93 avis d’attribution•124 lots attribués•55,56 M € au total
Warszawa, POL
27 332 € Ce contrat
23 avis d’attribution•40 lots attribués•13,40 M € au total
Wrocław, POL
3 726 € Ce contrat
163 avis d’attribution•427 lots attribués•249,13 M € au total
Lots attribués
| Lot | Titre | Lauréat | Valeur | CPV principal |
|---|---|---|---|---|
| LOT-0049 | AMGEN SP. Z O.O. | 675 059 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0051 | CENTRALA FARMACEUTYCZNA CEFARM SA | 518 452 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0050 | Abbvie Sp. z o.o. | 268 922 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0053 | Takeda Pharma Sp. z o. o. | 148 595 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0062 | Non précisé | 140 516 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0059 | Centrala Farmaceutyczna Cefarm SA | 111 078 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0047 | NEUCA SPÓŁKA AKCYJNA | 104 229 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0054 | AMGEN SP. Z O.O. | 82 243 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0055 | GSK Services Sp. z o.o. | 82 243 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0058 | AMGEN SP. Z O.O. | 54 266 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0052 | AstraZeneca Kft. | 38 097 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0060 | CENTRALA FARMACEUTYCZNA CEFARM SA | 28 104 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0046 | BAXTER POLSKA Sp. z o.o. | 27 332 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0061 | AMGEN SP. Z O.O. | 24 497 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0048 | AstraZeneca Kft. | 3 834 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0056 | URTICA Sp. z o.o. | 3 726 € | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) |